The impact of cyclooxygenase inhibitor use on urinary prostaglandin metabolites in preterm infants

Background: There is limited evidence on the association between the clinical course of patent ductus arteriosus (PDA) and prostaglandin (PG) metabolites. This study aimed to determine the influence of PDA treatment on urinary PG metabolite excretion in very-low-birth-weight (VLBW) infants. Methods:...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Natsuki Ohkawa, Hiromichi Shoji, Naho Ikeda, Yayoi Murano, Toshiaki Okuno, Masato Kantake, Takehiko Yokomizo, Toshiaki Shimizu
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2024-03-01
Serija:	Pediatrics and Neonatology
Teme:	cyclooxygenase-2 inhibitor ductus arteriosus infant preterm infant prostaglandins
Online dostop:	http://www.sciencedirect.com/science/article/pii/S1875957223001328
Oznake:	Označite Brez oznak, prvi označite!